← Open Payments lookup

MELISSA LONDON: Open Payments

NPI 1215495635 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,661 in 80 payments from 19 companies in 2025. Trend: 2023 $1,826 · 2024 $2,399 · 2025 $2,661

Food & beverage: $2,661
CompanyPaymentsAmount
Amgen Inc.9$446
AstraZeneca Pharmaceuticals LP8$298
Novartis Pharmaceuticals Corporation12$261
AKEBIA THERAPEUTICS INC5$236
Ascendis Pharma Endocrinology Inc4$204
OPKO Pharmaceuticals, LLC8$203
Calliditas Therapeutics US Inc.3$189
Mallinckrodt Hospital Products Inc.7$177
Bayer Healthcare Pharmaceuticals Inc.7$176
Ardelyx, Inc.3$100

Products named: OTEZLA, Vafseo, Yorvipath, RAYALDEE, TARPEYO, FARXIGA, Kerendia, ACTHAR.

Industry payments across CA — which companies pay providers there.